Brief: Lepu Biopharma Posts FY Loss Attributable RMB689.1 Million
17/03/2023 14:32
March 17 (Reuters) - Lepu Biopharma Co Ltd 2157.HK :
* FY LOSS ATTRIBUTABLE RMB689.1 MILLION VERSUS LOSS OF
RMB1.01
BILLION
* REVENUE WAS APPROXIMATELY RMB15.6 MILLION FOR YEAR
Source text for Eikon: ID:nHKS51Z9M1
Further company coverage: 2157.HK
((Reuters.Briefs@thomsonreuters.com;))
Recent news on Lepu Biopharma
See all newsChina's Lepu Biopharma H1 revenue rises 12.1% on higher drug sales
Hong Kong-listed Keymed Biosciences' gastric cancer drug meets late-stage trial goals
Brief: Lepu Biopharma Reports Positive Top-Line Results From Global Phase III Trial Of CMG901 (AZD0901)
Lepu Biopharma set to jump most in 7 months on FY profit forecast
Brief: Lepu Biopharma Expects FY Net Profit Attributable